Akèy › Kansè tete negatif triple › North Carolina › Winston-Salem
Etid klinik pou Kansè tete negatif triple nan Winston-Salem, NC
4 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Winston-Salem (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Ap rekriteFaz 2
- Wake Forest University Health Sciences, Winston-Salem
- Wake Forest University at Clemmons, Clemmons · 9 mi lwen
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- Atrium Health Wake Forest Baptist, Winston-Salem
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
Ap rekriteFaz 2
- Wake Forest Baptist Health Sciences, Winston-Salem
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Winston-Salem
- Kansè (tout kalite)19 etid
- Leksemi mieloïd egi18 etid
- Myelom Miltip14 etid
- Kansè nan tete14 etid
- Maladi kadyovaskilè14 etid
- Kansè Poumon ki pa ti selil12 etid
- BPCO10 etid
- Kansè ovè10 etid
- Dyabèt Tip 29 etid
- Sendwòm myelodisplastik9 etid
- Gliyoblastòm8 etid
- Lukemi lenfositè kwonik8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.